Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study

ConclusionsThe CATAP therapy demonstrated positive clinical activity and a favorable  safety profile for melanoma patients with liver metastasis.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research